Convergen
Convergen develops targeted protein degradation therapies for diseases associated with pathological protein aggregates.
$15M Seed ·
Source: AllSci
Funding history ↓Signals
Website registeredJan 13, 2021 (5 years old)
Funding rounds
Timeline
- Website created
Founders and team
JS
Jinquan Sun Founder
Companies like Convergen
CCasma Therapeutics$46M Series B+ · Nov 2022
BBindbridge$3.8M Pre Seed · Mar 2026
BBoulevard Bio$65M Seed · Aug 2026
VVaderis Therapeutics$152M Series B+ · Aug 2026
EExcalipoint TherapeticsSeed · Mar 2026
SSplice Bio$140M Series B+ · Jun 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/convergen (get a free API key).